How severe is CVE-2023-22868?

CVE-2023-22868 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2023-22868 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (33rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-22868?

CVE-2023-22868 primarily affects Ibm Aspera Faspex. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2023-22868?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2023-22868 published?

CVE-2023-22868 was published on 2023-02-17 and last updated on 2026-06-17.

CVE-2023-22868

CVE-2023-22868 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 5.4)
EPSS exploit prediction: 0% (33rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-79
Affected product: Ibm Aspera Faspex
Published: 2023-02-17
Last modified: 2026-06-17

Description

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Frequently asked questions

What is CVE-2023-22868?: IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
How severe is CVE-2023-22868?: CVE-2023-22868 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2023-22868 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (33rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-22868?: CVE-2023-22868 primarily affects Ibm Aspera Faspex. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-22868?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-22868 published?: CVE-2023-22868 was published on 2023-02-17 and last updated on 2026-06-17.

References

Affected products (2)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.1:patch_level_1:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2026-14959 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
CVE-2026-14958 — Critical (CVSS 9.1): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to…
CVE-2026-14996 — High (CVSS 8.2): IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 has addressed a vulnerability related to session management.
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2026-106102 — Critical (CVSS 10.0): Quasar Framework is a framework for building high-performance Vue.js user interfaces. Prior to 2.22.0, the SSR-only…
CVE-2026-59167 — Critical (CVSS 10.0): SunEditor is a lightweight and powerful WYSIWYG editor in vanilla JavaScript with no dependencies. Prior to 2.47.11,…
CVE-2026-85061 — Critical (CVSS 10.0): MapLibre GL JS is an interactive vector tile map library for web browsers. Prior to 6.4.1, DOM.sanitize() in…
CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →